松瑞藥
416718.40−0.50−2.65%收盤・資料日 2026-11-06
每股盈餘左軸 EPS、右軸股價
2026 Q22.33 元—
單季 EPS（元）
202120222023202420252026
盈餘表新到舊
| 季別 | EPS（元） | 季增率 | 年增率 |
|---|---|---|---|
| 2026 Q2 | 2.33 | +703.45% | — |
| 2026 Q1 | 0.29 | 0.00% | −76.23% |
| 2026 Q1–Q2 合計 | 2.62 | +123.93% | |
| 2025 Q4 | 0.29 | +11.54% | +107.14% |
| 2025 Q3 | 0.26 | — | +100.00% |
| 2025 Q2 | −0.05 | −104.10% | −171.43% |
| 2025 Q1 | 1.22 | +771.43% | +454.55% |
| 2025 全年合計 | 1.72 | +207.14% | |
| 2024 Q4 | 0.14 | +7.69% | +7.69% |
| 2024 Q3 | 0.13 | +85.71% | — |
| 2024 Q2 | 0.07 | −68.18% | +250.00% |
| 2024 Q1 | 0.22 | +69.23% | — |
| 2024 全年合計 | 0.56 | +522.22% | |
| 2023 Q4 | 0.13 | — | — |
| 2023 Q3 | −0.05 | −350.00% | −111.90% |
| 2023 Q2 | 0.02 | — | — |
| 2023 Q1 | −0.01 | — | — |
| 2023 全年合計 | 0.09 | −25.00% | |
| 2022 Q4 | −0.13 | −130.95% | — |
| 2022 Q3 | 0.42 | — | — |
| 2022 Q2 | 0.00 | — | −100.00% |
| 2022 Q1 | −0.17 | — | −162.96% |
| 2022 全年合計 | 0.12 | +140.00% | |
| 2021 Q4 | −0.09 | — | −129.03% |
| 2021 Q3 | −0.18 | −460.00% | −220.00% |
| 2021 全年合計 | 0.05 | −94.32% |
三率
2026 Q236.67%5.53%270.21%
三率（%）
202120222023202420252026
三率明細單季
| 期間 | 毛利率 | 營益率 | 淨利率 |
|---|---|---|---|
| 2026 Q2 | 36.67% | 5.53% | 270.21% |
| 2026 Q1 | 30.97% | 8.17% | 38.62% |
| 2025 Q4 | 30.12% | 9.56% | 27.24% |
| 2025 Q3 | 35.95% | 15.20% | 27.99% |
| 2025 Q2 | 38.23% | 24.44% | −5.27% |
| 2025 Q1 | 36.86% | 10.14% | 145.96% |
| 2024 Q4 | 29.60% | 6.23% | 16.53% |
| 2024 Q3 | 37.32% | 22.24% | 12.62% |
| 2024 Q2 | 24.94% | 8.85% | 5.99% |
| 2024 Q1 | 20.74% | −1.22% | 26.92% |
| 2023 Q4 | 41.65% | 24.91% | 13.64% |
| 2023 Q3 | 2.27% | −17.08% | −5.91% |
| 2023 Q2 | 12.91% | −12.85% | 2.10% |
| 2023 Q1 | 23.97% | −1.76% | −1.60% |
| 2022 Q4 | 11.94% | −8.15% | −16.05% |
| 2022 Q3 | 12.77% | −3.46% | 38.11% |
| 2022 Q2 | 14.75% | −0.82% | −0.43% |
| 2022 Q1 | 1.20% | −19.06% | −17.58% |
| 2021 Q4 | 8.00% | −8.00% | −8.77% |
| 2021 Q3 | 4.01% | −16.75% | −15.00% |
ROE 拆解每季都是近四季合計
2026 Q2近四季
ROE27.52%+15.05 個百分點
＝淨利率91.73%+54.07 個百分點
×總資產週轉0.26 次−0.04 次
×權益乘數1.16 倍+0.04 倍
ROA 22.05%。和 2025 Q2 比，ROE 增加，變動比率最大的是淨利率。
2026 Q227.52%22.05%
ROE、ROA（近四季合計，%）
202120222023202420252026
2026 Q291.73%
淨利率（近四季，%）
202120222023202420252026
2026 Q20.26 次
總資產週轉（近四季合計，次）
202120222023202420252026
2026 Q21.16 倍
權益乘數（倍）
202120222023202420252026
ROE 明細每季都是近四季合計
| 期間 | ROE | ROA | 淨利率 | 總資產週轉（次） | 權益乘數（倍） |
|---|---|---|---|---|---|
| 2026 Q2 | 27.52% | 22.05% | 91.73% | 0.26 | 1.16 |
| 2026 Q1 | 6.81% | 5.67% | 20.38% | 0.28 | 1.19 |
| 2025 Q4 | 14.39% | 12.54% | 44.41% | 0.29 | 1.13 |
| 2025 Q3 | 13.38% | 11.56% | 42.48% | 0.28 | 1.13 |
| 2025 Q2 | 12.48% | 10.72% | 37.66% | 0.30 | 1.12 |
| 2025 Q1 | 13.27% | 11.68% | 40.41% | 0.30 | 1.08 |
| 2024 Q4 | 5.15% | 4.55% | 14.66% | 0.31 | 1.13 |
| 2024 Q3 | 4.76% | 4.58% | 13.99% | 0.33 | 1.04 |
| 2024 Q2 | 3.06% | 3.04% | 9.65% | 0.32 | 1.00 |
| 2024 Q1 | 2.73% | 2.62% | 9.27% | 0.28 | 1.04 |
| 2023 Q4 | 0.82% | 0.73% | 2.62% | 0.27 | 1.18 |
| 2023 Q3 | −1.69% | −1.34% | −5.74% | 0.24 | 1.23 |
| 2023 Q2 | 2.83% | 1.91% | 8.88% | 0.24 | 1.34 |
| 2023 Q1 | 2.66% | 1.77% | 7.35% | 0.26 | 1.41 |
| 2022 Q4 | 1.05% | 0.66% | 2.87% | 0.27 | 1.34 |
| 2022 Q3 | −0.77% | 0.95% | 3.54% | 0.29 | — |
| 2022 Q2 | −6.39% | −3.06% | −10.29% | 0.29 | 2.11 |
| 2022 Q1 | −6.00% | −2.69% | −8.03% | 0.33 | 2.27 |
| 2021 Q4 | −2.07% | 0.16% | 0.57% | 0.37 | — |
| 2021 Q3 | 1.18% | 2.71% | 6.62% | 0.41 | 0.43 |
財經資料來源：FinLab